232 related articles for article (PubMed ID: 11309338)
1. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer.
Terakawa N; Kanamori Y; Yoshida S
Endocr Relat Cancer; 2003 Jun; 10(2):203-8. PubMed ID: 12790783
[TBL] [Abstract][Full Text] [Related]
3. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
4. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
6. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
Gagnon V; St-Germain ME; Parent S; Asselin E
Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
[TBL] [Abstract][Full Text] [Related]
7. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
[TBL] [Abstract][Full Text] [Related]
8. [PTEN expression in endometrial cancer and the prognosis].
Kanamori Y; Uegaki K; Kigawa J; Terakawa N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
[No Abstract] [Full Text] [Related]
9. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
10. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
[TBL] [Abstract][Full Text] [Related]
11. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.
She QB; Solit DB; Ye Q; O'Reilly KE; Lobo J; Rosen N
Cancer Cell; 2005 Oct; 8(4):287-97. PubMed ID: 16226704
[TBL] [Abstract][Full Text] [Related]
12. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway.
Wan X; Yokoyama Y; Shinohara A; Takahashi Y; Tamaya T
Cell Death Differ; 2002 Apr; 9(4):414-20. PubMed ID: 11965494
[TBL] [Abstract][Full Text] [Related]
13. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.
Lilja JF; Wu D; Reynolds RK; Lin J
Anticancer Res; 2001; 21(3B):1969-74. PubMed ID: 11497285
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent.
Guzeloglu Kayisli O; Kayisli UA; Luleci G; Arici A
Biol Reprod; 2004 Sep; 71(3):714-21. PubMed ID: 15115729
[TBL] [Abstract][Full Text] [Related]
15. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
16. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
17. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
18. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
19. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.
Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164
[TBL] [Abstract][Full Text] [Related]
20. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
